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Abstract: Poly(hydroxybutyrate-co-hydroxyvalerate) (PHBV) is a piezoelectric biodegradable
and biocompatible polymer suitable for tissue engineering applications. The incorporation of
magnetostrictive cobalt ferrites (CFO) into PHBV matrix enables the production of magnetically
responsive composites, which proved to be effective in the differentiation of a variety of cells and tissues.
In this work, PHBV and PHBV with CFO nanoparticles were produced in the form of films, fibers and
porous scaffolds and subjected to an experimental program allowing to evaluate the degradation process
under biological conditions for a period up to 8 weeks. The morphology, physical, chemical and thermal
properties were evaluated, together with the weight loss of the samples during the in vitro degradation
assays. No major changes in the mentioned properties were found, thus proving its applicability for
tissue engineering applications. Degradation was apparent from week 4 and onwards, leading to the
conclusion that the degradation ratio of the material is suitable for a large range of tissue engineering
applications. Further, it was found that the degradation of the samples maintain the biocompatibility
of the materials for the pristine polymer, but can lead to cytotoxic effects when the magnetic CFO
nanoparticles are exposed, being therefore needed, for magnetoactive applications, to substitute them
by biocompatible ferrites, such as an iron oxide (Fe3O4).
Keywords: piezoelectric materials; poly(hydroxybutyrate-co-hydroxyvalerate); hydrolytic degradation;
tissue engineering
1. Introduction
Polymeric materials with different morphologies are processed as scaffolds to mimic the
extracellular matrix (ECM) and to manipulate cell response and engineer specific tissues [1]. Thus,
a proper biomimetic strategy must allow the scaffold to mimic the native tissue environment, including
morphological features, conditions and stimuli, to stimulate cells in a specific differentiation path [2–4].
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In particular, smart polymers are gaining increasing attention as substrates and
scaffolds for tissue engineering applications mainly as electroactive substrates—mostly
piezoelectric ones—such as poly(l-lactic acid) (PLLA) [5,6], poly(hydroxybutyrate) (PHB) [7],
poly(hydroxybutyrate-co-hydroxyvalerate) (PHBV) [8,9] and poly(vinylidene fluoride) (PVDF) [10,11],
among others. The ability of those materials to actively enhance and stimulate cellular differentiation
processes has been already proven [12,13], based on their mechano-transduction characteristics,
generating voltage upon mechanical stimulation and vice-versa [14]. Piezoelectricity is a property
that appears in a diversity of human tissues, including DNA, bones or tendons, emphasizing the
relevance of electrical and mechano-electrical stimulation in physiological processes [15,16]. In a
different approach to apply mechanical and/or mechano-electrical signals, magnetoelectric materials
have also proven their aptness for tissue engineering applications, with the particularity of allowing
electrical stimulation of the materials and, therefore, on the cells cultured on them, through magnetic
solicitation [17,18]. These materials can generate voltage upon magnetic stimulation through the
coupling of the magnetostrictive effect (magnetic to mechanical) and piezoelectric effect (mechanical
to electric) [19,20]. Magnetoelectric composites are thus achieved combining a piezoelectric polymer
with magnetostrictive particles [21–23], and their potential for tissue engineering and enhancement of
cellular differentiation processes has been demonstrated [24,25].
In some tissue engineering applications, it is suitable that the used scaffolds degrade in a biological
environment to be gradually replaced by the newly formed tissue [26]. In this context, the most used
piezoelectric materials for tissue engineering applications belong to the poly(vinylidene fluoride)
family [12] and do not possess biodegradability, which may hinder some applications [27]. Further,
the other often used biomaterial, poly(l-lactic acid) (PLLA), shows a piezoelectric response, however
with a slow degradation rate [12].
Poly(hydroxybutyrate-co-hydroxyvalerate), PHBV, is a PHB copolymer that was developed to
enhance PHB toughness and processability, widening its industrial applications [28,29]. PHBV is a
biocompatible, biodegradable, highly absorbent, non-toxic thermoplastic. Together, all these properties
make it a promising candidate material for biomedical applications, such as the fabrication of cardiac
stents [30], wound dressing [31], drug release [32] and antitumor applications [33]. More specifically
in tissue engineering, PHBV is usually employed for scaffolds in bone tissue regeneration [34,35],
absorbable surgical sutures [36], among others.
Additionally, owing to its piezoelectric properties (piezoelectric coefficient of 1.3 pC/N, similar to
human bone [12,37]), this polymer can provide electrical stimulation through mechanical solicitation
and with a suitable degradation rate for a variety of tissue engineering applications [38,39].
In addition to tissue engineering applications, PHBV has a wide range of industrial applications
such as food packaging [40], cosmetics, personal care products (towels and diapers), helmets and
panels for several automotive materials [41–43]. More recently, this polymer was also used in the scope
of environmental remediation towards nitrates and chlorine removal from contaminated water [44,45].
A biodegradable magnetoelectric composite, combining piezoelectric PHBV with magnetostrictive
cobalt ferrites, CoFe2O4 (CFO) has been reported [8], confirming the ability of biodegradable PHBV
and magnetoelectric compound (PHBV/CFO) to be processed into different morphologies, including
microspheres, films, fibers and 3D porous scaffolds, adequate for tissue engineering applications with
different structural microenvironments.
As the biodegradation process occurs, it is important to keep the properties that assure the
effectiveness of the scaffold after its implantation. For this reason, morphological, physicochemical and
magnetic properties must be evaluated after exposure of the samples to a physiological environment
for a given time.
The work herein presented reports on the degradation of pristine PHBV and PHBV/CFO composite
samples, both in the form of film, fiber and porous scaffold. Degradation took place for 8 weeks in
contact with simulated body fluid (SBF) with ion concentration found in human plasma, allowing to
provide insights on materials characteristics upon implantation. These results will help to fill the gap
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in the areas of (a) PHBV’s degradation in biological media, (b) degradation behavior of the materials
depending on functional microstructures and (c) in the area of magnetoelectric compounds for tissue
engineering purposes [24,46], in which the degradation behavior in a simulated biological environment
has never been addressed.
2. Experimental
2.1. Materials
Poly(hydroxybutyrate-co-hydroxyvalerate), PHBV, (3% HV mol/mol, molecular weight of
460.64 g mol−1, 99% purity) was purchased from Natureplast (IFS, France). Chloroform (molecular
weight of 119.38 g mol−1, 99% purity) was purchased from Fischer (Porto Salvo, Portugal, C/4960/17).
CFO molecular weight 234.62 g mol−1, reference 1510FY, 98% purity and 35–55 nm size range) was
obtained from Nanoamor (Katy, TX, USA). Sodium Chloride (molecular weight of 58.55 g mol−1,
98% purity, reference S/3160/60) was purchased from Fisher (Porto Salvo, Portugal).
2.2. Sample Processing
Samples were prepared from either a 10% (w/v) polymer solution of PHBV in chloroform or a
composite solution of 10% (w/v) PHBV on chloroform with 10% (w/w) CFO [8]. In the later, CFO were
sonicated for 1.5 h in chloroform before polymer dissolution. The CoFe2O4 concentration was selected
due to not comprising the biocompatibility [47].
Different techniques were used to produce different morphologies and structures from both
polymer and composite solutions.
Polymer films were obtained by solvent-casting. The polymer/composite solution was poured
over a glass substrate, spread with a blade and left at room temperature for 2 days until the solvent
has evaporated. After removal from the glass substrate, mechanically robust, self-standing films
were obtained.
Fibrous samples were produced by electrospinning. Fibers were electrospun with a flow rate
of 2 mL h−1 (Syringe pump) and an electrospinning voltage of 20 kV (Matsusada AU-30P1-L power
source). Fibers were collected on a flat static collector set at 20 cm between needle tip (diameter of
0.5 mm) and collector.
Porous 3D scaffolds were produced according to the solvent-casting/particulate-leaching technique.
For that, 10 g of NaCl, acting as porogen agent, was placed in a Petri dish and covered with 10 mL of
polymer/composite solution. Solution and porogen were homogeneously mixed, and the Petri dish
was then left at room temperature until the solvent was completely evaporated. Then, the Petri dish
was immersed in deionized water to dissolve/release the porogen. Water was changed daily to avoid
saturation and agitated at least twice a day. The porogen leaching procedure was carried out for 3 days.
Then, the 3D scaffold was removed from the water and let to dry at room temperature.
2.3. Degradation Assays
For the degradation assays, simulated body fluid (SBF) was prepared according to [48]. Briefly,
SBF was obtained by adding to 700 mL of ultrapure water under mechanical agitation the following
components: NaCl (8.04 g), NaHCO3 (0.36 g), KCl (0.23 g), K2HPO3H2O (0.23 g), MgCl2.6H2O (0.31 g),
HCl (39 mL), CaCl2 (0.29 g), Na2SO4 (0.07 g) and TRIS (6.12 g). After complete dissolution, the pH has
been adjusted to 7.4 and completed the volume of 1 L. The samples from the different materials were
cut in 1 cm2 pieces and immersed in 3 mL of SBF at 37 ◦C in 12-well tissue culture polystyrene plates
(Figure 1).
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Figure 1. Schematic representation of the steps involved in the degradation assays.
The fluid was exchanged weekly avoiding changes in pH and ion concentration. Samples were
immersed for 1, 2, 4, 6 and 8 week periods. The fluid was produced to mimic ion concentration in
blood plasma, according to [48].
2.4. Morphological Analysis
The samples were characterized before and after the degradation assay to evaluate possible
morphological changes. For that, the samples were placed in aluminum pans and sputter-coated with
a thin layer of gold with a Polaron SC502 instrument (East Sussex, UK). The images of the samples
were acquired on a FEG-SEM Hitachi set up with a 3 kV voltage.
2.5. Chemical Structure Analysis
Changes in the samples chemical structure due to the degradation process were evaluated by
Fourier Transform Infrared Spectroscopy (FTIR) at room temperature with a Jasco FT/IR 4100 instrument
(Jasco, E ston, MD, USA) in the Attenuated Total Reflection (ATR) mode. A total of 64 scans were used
for m asu ement with a resolution of 4 cm−1 in the 400–6000 cm−1 range.
2.6. Thermal Analysis
Thermal properties were assessed by differential scanning calorimetry (DSC) with a Mettler Toledo
DSC823e apparatus (Mettler Toledo, Columbus, OH, USA) at 10 ◦C min−1 heating rate in the 0–200 ◦C
temperature range. Measurements were carried out in a nitroge atmosphere in 40 µL aluminum pans.
2.7. Elemental Surface Composition Analysis
X-ray hotoelectron spectroscopy (XPS) was performed to evaluate the surface elemental
composition and atomic concentration of non-degraded and degraded samples in a Kratos AXIS
Ultra HSA, with VISION software for data acquisition and CASAXPS software for data analysis.
The experiments were carried out with a monochromatic Al Kα X-ray source (1486.7 eV), operating at
15 kV (90 W), in Fixed Analyzer Transmission (FAT) mode, with a pass energy of 40 eV for regions ROI
and 80 eV for a survey. The acquisition of the data was performed with a pressure lower than 1 × 10−6 Pa
using a charge neutralization system. The electric charge effect was corrected by the reference of the
carbon peak (284.6 eV). The binding energies (BEs) were referenced to the C1s hydrocarbon peak at
286.4 eV. The resulted spectra were analyzed using the CASA XPS software (version 2.3.15, CASA
Software Ltd, Teignmouth, UK). For the curve fitting of the high-resolution spectra of the samples,
30% Gaussian/70% Lorentzian mixed line shapes were used.
2.8. Weight Loss Assessment
Samples weight was measured before an after the contact with the degradation medium (SBF).
Then, samples withdrawn from SBF medium after 1, 4, 6 and 8 weeks were dried at room temperature
for at l ast two week , and the mass was measured with an XS balance BL 224 ± 0.1 mg. Three replicas
were used for each of the degradation intervals.
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2.9. Cytotoxic Assay
Indirect cytotoxicity evaluation of the different samples after 6 weeks of degradation was performed
adapting the ISO 10993-5 standard test method.
MC3T3-E1 pre-osteoblast cells (Riken cell bank, Tsukuba, Japan) were cultured in 75 cm2 cell
culture flask at 37 ◦C in a humidified environment and 5% CO2, using Dulbecco’s modified Eagle’s
medium (DMEM, Biochrom, Berlin, Germany) containing 1 g L−1 glucose, 10% fetal bovine serum
(FBS, Biochrom, Berlin, Germany) and 1% (v/v) penicillin/streptomycin solution (P/S, Biochrom).
The sterilization of the samples was carried out by exposition to ultraviolet radiation for 1 h each
side of the samples and washing with sterile phosphate-buffered saline solution (PBS, pH 7.4). Then,
a suspension of 2 × 104 cell mL−1 was seeded in 96-well tissue culture polystyrene plates and incubated
for 24 h at the same conditions described above to ensure cell attachment on the plate. Simultaneously,
each sample was incubated for 24 h in a 24-well tissue culture polystyrene plate. After the incubation
time, the cell culture medium in the 96-well plates was removed, and 100 µL of culture medium (that
was in contact with the different samples) was added to each well. Metabolic activity was then evaluated
after 72 h of incubation using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT)
proliferation assay according to the manufacturer’s instructions (Sigma-Aldrich, Sintra, Portugal).
Briefly, the medium of every well was removed, and fresh medium containing MTT solution
(5 mg mL−1 of MTT dissolved in DMEM in a 1:10 ratio) was added to the cells and incubated for 2 h at
37 ◦C in the dark. Then, the MTT solution was removed, and the precipitated formazan was dissolved
with 100 µL dimethyl sulfoxide (DMSO)/well followed by measuring the optical density at 570 nm.
All quantitative results were obtained from four replicate samples and presented as the average of
viability ± standard deviation. The percentage of metabolic activity was calculated according to the
equation reported in [49], where:
Metabolic activity (%) = (Absorbance o f sample/Absorbance o f negative control)×100
3. Results and Discussion
3.1. Samples Macrostructure
Figure 2 shows the PHBV and PHBV/CFO samples along the degradation process (the samples
before degradation look similar to the ones in week 1). Significant changes are observed in the samples,
in particular in the ones with fiber morphology, after four weeks of degradation.
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Figure 2. Poly(3-hydroxybutyrate-co-hydroxyvalerate) (PHBV) and PHBV/cobalt ferrite (CFO) films,
scaffolds and fibers after 1, 2, 4 and 6 weeks immersion in simulated body fluid (SBF) at 37 ◦C.
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This visual assessment indicates that the samples with higher surface area exhibit a more advanced
state of degradation after a given time, which is consistent with the degradation process of PHBV,
which is caused by hydrolyzation of the polymers water solvable portions [50]. Thus, a higher surface
area offers a larger interaction of the polymer with water.
After 8 weeks, severe degradation is observed in fibers and scaffolds, yielding the smallest samples
residues (results not shown). On the contrary, both films showed little degradation and maintain a
more pristine look throughout the assay, as verified in Figure 2. In this sense, all the morphological and
physical-chemical properties were evaluated for the degraded samples after 6 weeks of immersion in
SBF medium.
3.2. Samples Microstructure
The morphology of all films and electrospun fibers before and after the degradation process was
analyzed by SEM (Figure 3), where the degradation is best noticed for all the samples at week 6.
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Figure 3. Cross-section SEM images of representative samples: PHBV/CFO films (a,b), PHBV fibers
(c,d), PHBV/CFO fibers (e,f) and PHBV/CFO scaffolds (g,h), befor and after degradation respectively.
PHBV/CFO composite films (Figure 3a) reveal a homogeneous and non-porous surface, showing
that the CFO particles are incorporated into the PHBV polymer matrix. The electrospun PHBV and
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PHBV/CFO fibers (Figure 3c,e, respectively) are characterized by a rather smooth, in particular for the
pristine polymer- and high surface area with a large porous network. The fibers surface area increases
due to the CFO incorporation into the PHBV matrix [8], as also confirmed by the increase in surface
roughness and irregularities observed in Figure 3e for the composite sample in comparison with
Figure 3c for the pristine polymer.
After 6 weeks of degradation, a significant erosion of both pristine (results not shown) and
composite films occurs, increasing the surface roughness and being possible to observe the CFO
particles within the PHBV matrix (Figure 3b). The erosion is homogenous all along the samples and
similar for both pristine and composite materials, i.e., the presence of CFO nanofillers does not seem to
influence the degradation process.
Relatively to the degradation of electrospun PHBV and PHBV/CFO fibers, Figure 3f,h, after 6 weeks
of degradation, the composite fibers exhibit a rough and porous surface, while the pristine ones reveal
a smooth surface. Similarly, to the composite films, some round structures can be observed in Figure 3h
which represent CFO agglomerates exposed after the polymer degradation.
Comparing the different morphologies, it is verified a faster/advanced degradation state in fibers
and scaffolds when compared to films, as observed in Figure 2. This is explained, as previously
mentioned, by the larger surface area of fibers and scaffolds exposed to the degradation medium,
allowing increased contact between the solution and the polymer.
3.3. Chemical Analysis
FTIR spectra of the samples before and after six weeks of degradation are shown in Figure 4. It is
observed that no differences occur after the degradation process: the same characteristic absorption bands
are observed for the degraded samples as for the PHBV pristine morphologies. Thus, the absorption
bands at 826–979 cm−1 and 1227–1478 cm−1 corresponding to C-H vibrations, and at 1057 cm−1,
1133 cm−1 and 1183 cm−1 corresponding to C-O vibrations, are present in both pristine and composite
samples [51]. The absorption bands at 2934 cm−1 are attributed to the C-H groups stretching. Additionally,
independently of the morphology, Figure 3a,b, show no differences for the different PHBV/CFO samples,
indicating that there is no chemical interaction between the polymer and CFO nanoparticles [8]. In this
sense, both the morphological variations and the inclusion of CFO into the PHBV matrix does not
promote changes in the molecular structure or affects the degradation mechanism of the polymer
(Figure 4a,b). Figure 4b also shows a general decrease in the absorption bands intensity for both PHBV
and PHBV/CFO composites, being more evidenced in fibers and scaffolds as a result of the degradation
process, which is an indication of the scission of the PHBV bonds linkage.
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3.4. Thermal Analysis
DSC analysis was performed on pristine and degraded samples to evaluate the effect of the
degradation process in the thermal properties of the samples (Figure 4c,d). Independently of the sample
morphology, both for pristine and PHBV/CFO composites no major changes were verified between
the pristine samples (Figure 4c), being characterized by a melting process with melting temperature
(Tm) values around 160 to 180 ◦C. For pristine degraded PHBV films, fibers and scaffolds, peaks are
observed at 161, 131 and 154 ◦C, respectively, (Figure 4d) indicating that the degradation process of the
samples leads to a crystalline phase destabilization, starting the samples fusion at lower temperatures.
Further, with the exception of the PHBV/CFO scaffolds, and as stated in [8], neither processing nor the
addition of 10% CFO leads to any relevant modifications of the thermal characteristics of the samples.
Similarly, after six weeks of degradation in SBF, the thermal properties of the different samples were
not altered (Figure 4d). The Tm, ∆Hm and crystallinity degree (Xc) values of the different non-degraded
and degraded PHBV and PHBV/CFO samples are shown in Table 1.
Table 1. Tm, ∆Hm and XC of PHBV and PHBV/CFO composite non-degraded [8] and degraded samples.
The associated error is ±2%.
Sample Tm (◦C) ∆Hm (J/g) XC (%)
Films
PHBV 174 82 56
PHBV/CFO 177 70 48
PHBV (Degraded) 173 40 27
PHBV/CFO (Degraded) 173 66 45
Fibers
PHBV 175 98 67
PHBV/CFO 177 67 46
PHBV (Degraded) 171 49 33
PHBV/CFO (Degraded) 172 66 45
Scaffolds
PHBV (Degraded) 176 45 31
PHBV/CFO (Degraded) 173 37 25
From the enthalpy of the melting peak, the degree of crystallinity (XC) of the PHBV and PHBV/CFO
samples with the different morphologies was obtained by applying Equation (1).
Xc =
∆Hm
∆Hm100
(1)
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where Xc is the degree of crystallinity, ∆H represents the area of the melting peaks, ∆Hm the enthalpy
of the PHBV samples and ∆Hm100 the enthalpy of 100% crystalline PHBV (146.6 J mol−1) [52].
Taking into account the crystallinity degree values observed in a previous study for the different
PHBV and PHBV/CFO morphologies [8], independently of the morphology, all the degraded samples
show a decrease in the degree of crystallinity. It is important to mention that in fact there are differences
in the degree of crystallinity of the different non-degraded samples, as reported and discussed in [8].
These differences are entirely related to the different processing methods, in which important differences
in solvent evaporation conditions and crystallization dynamics are involved, main parameters affecting
the degree of crystallinity of the obtained samples. Regarding the degraded samples, the highest value
of crystallinity being observed for pristine films and fibers, decreasing the crystallinity degree from
56 to 27% and 67 to 33%, respectively [8]. This decrease in the amount of crystallinity for all samples,
when compared to the non-degraded samples, indicates a swelling effect of the amorphous part of
the samples during the degradation process and degradation of the crystalline phase of the polymer.
Further, the swelling effect is more effective for the samples that initially present higher crystallinity.
3.5. Elemental Surface Composition Analysis
XPS analysis was performed to study the chemical degradation of PHBV and PHBV/CFO samples
Figure 5.
The atomic surface composition was evaluated from C1s and O1s scanning spectra.
Independently of the PHBV morphology, for all the non-degraded PHBV and PHBV/CFO samples, the
C1s spectra presents three peaks at 288.2 eV, 286.2 eV and 285.1 eV, attributed to the aliphatic –C=O,
–C–O–C– and –C–C–/–C–H bonds of PHBV, respectively [53,54]. After the hydrolytic degradation, a
decrease in the intensity of the peak at 288.2 eV related to the -C=O bond is observed. In addition,
the intensity of the peaks at 286.2 eV and 285.1 eV slightly decreases with the degradation process
(Figure 5a–c). These results are indicative that the hydrolytic degradation induces the breakdown of
the PHBV bonds. It is also to notice that pristine and PHBV/CFO composite fibers and scaffolds present
the highest decrease in the peak intensity, showing that the sample morphology influences the PHBV
degradation. No significant changes are observed between the pristine and composite samples.
Figure 5d shows the representative O1s spectra for non-degraded and degraded PHBV films.
Similar results are observed for the other PHBV and PHBV/CFO morphologies. For the non-degraded
films, two peaks 531 and 532 eV are observed, corresponding to the aliphatic -C=O and -C-O
bonds [53–55]. After the PHBV degradation, all samples (neat and PHBV/CFO composites) show just a
single peak, which is indicative of the -C=O breakdown. The elemental composition of the samples is
presented in Table 2.
From the elemental compositions summarized in Table 2, it is observed that the PHBV and
PHBV/CFO non-degraded surface of the films is composed of ~70% of carbon and 30% of oxygen.
Similar results are observed for the non-degraded fibers and scaffolds. After the degradation process,
as it is also observed in the XPS spectra, clear alterations occur in the elemental composition of the
samples. As shown in Table 2, the amount of carbon decreases for the PHBV and PHBV/CFO degraded
samples and the amount of oxygen increases, increasing the O/C atom ratio. This fact is an indication
that, during the hydrolytic degradation, the C-C and C-H bonds scission occurs preferentially due
to the strength of the C=O (749 kJ mol−1) and C-O (360 kJ mol−1) bonds, as schematically illustrated
in Figure 6. Further, attending to the results presented in Figure 5 and Table 2, and the schematic
representation of the degradation mechanism in Figure 6, it is also possible to conclude that the
presence of CFO into the PHBV polymer matrix does not influence significantly the PHBV degradation
process, as, independently of the morphology, the incorporation of CFO does not promote relevant
changes in the elemental composition of the samples (Table 2).
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Figure 5. XPS results of non-degraded and degraded PHBV and PHBV/CFO samples with different
morphologies: (a–c) C1s scan spectra for films, fibers and scaffolds, respectively and (d) O1s spectra.
Table 2. Surface chemical composition of non-degraded and degraded PHBV and PHBV/CFO samples.
Samples Elemental Composition (%)
C O O/C
Non-degraded
PHBV film 69.4 30.6 0.44
PHBV/CFO film 71.9 28.1 0.39
PHBV fibers 70.3 29.7 0.42
PHBV/CFO fibers 69.0 31.0 0.45
PHBV scaffolds 73.2 26.8 0.37
PHBV/CFO scaffolds 73.3 26.7 0.36
Degraded
PHBV film 66.8 33.3 0.49
PHBV/CFO film 63.7 36.0 0.56
PHBV fibers 69.3 30.7 0.44
PHBV/CFO fibers 66.5 33.4 0.50
PHBV scaffolds 63.2 36.8 0.58
PHBV/CFO scaffolds 68.3 31.7 0.46
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3.6. Weight Loss
The weight loss as a function of time for the different samples morphology is shown in Figure 7.
As observed, the weight loss is independent of the samples morphology, occurring along the different
weeks. For pristine samples, and due to the high surface area of the fibers and scaffolds, which promotes
a higher contact with the SBF medium, the highest weight loss is observed for those morphologies.
After two weeks, pristine films reveal a weigh loss of ~2%, increasing the weight loss to ~5.5% in week
6 and 8. For PHBV fibers and scaffolds, the weight loss increase from 24% (week 2) to 70% and from
9% to 51%, respectively (week 8), which is in agreement with the results shown in Figure 2.
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along ti e due to the high porous structure of these morphologies when compared with the dense and
compact films. Fur r, Figure 7 also shows that the inclusion of CFO parti les into the PHBV matrix
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3.7. Cytotoxic Analysis
The PHBV and PHBV/CFO samples produced with different morphologies show no cytotoxic
behavior [8], proving for the composite samples that the CFO is fully incorporated into the polymer
matrix. Degradation can lead to cytotoxic effects either due to the exposure of specific polymer groups
or to the presence of exposed CFO. Thus, the samples obtained after six weeks of degradation were
submitted to a cytotoxic assay, and the metabolic activity is presented in Figure 8.
Figure 8 shows that all samples remain non cytotoxic (metabolic activity values higher than 70%,
according to the ISO 10993-5) except for the PHBV/CFO scaffold, which is the one of the samples with
the larger exposed surface area and with encapsulated CFO nanoparticles. In this way, it is confirmed
that the degradation of PHBV does not lead to the formation of cytotoxic components. On the other
hand, for composites samples, and once CFO can show cytotoxic effects [57], it is possible to infer that
the particles continue efficiently encapsulated, excepting in the case of the scaffold morphology, as it
suffers the largest degradation among the different samples. Therefore, an alternative to CFO, such as
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an iron oxide (Fe3O4), with lower magnetization and magnetostriction, but biocompatible, can be used
for tissue engineering applications when the piezoelectric polymer is expected to be degraded.
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4. Conclusions
Electroactive poly(3-hydroxybutyrate-co-hydroxyvalerate) (PHBV) with and without cobalt ferrite,
CFO, nanoparticles were produced in the form of films, fibers and scaffolds. These materials were
placed in contact with a simulated body fluid up to 8 weeks in order to study their degradation.
For this purpose, the morphology, physical, chemical and thermal properties were evaluated. It is
shown that the degradation process mainly affects the morphology and the degree of crystallinity of the
samples. The elemental surface composition analysis shows that the hydrolytic degradation induces
the breakdown of the PHBV bonds, not affecting the cytotoxic behavior of PHBV and PHBV/CFO
samples, which are not cytotoxic, except the PHBV/CFO scaffold, due to the exposition of the CFO
fillers after the degradation of the polymer. Hence, the proposed systems show suitability for magneto
and electro-active tissue engineering applications, but magnetic fillers such as biocompatible Fe3O4,
must be used when the piezoelectric materials are expected/needed to be degraded and the magnetic
fillers exposed or released.
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